| 1. | | Recruiting | Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer
Condition: Colorectal Neoplasms |
| 2. | | Recruiting | Study of the Litx™ System Combined with Chemotherapy in Patients With Colorectal Liver Metastases
Conditions: Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis |
| 3. | | Recruiting | Study of Erbitux (cetuximab) Given Alone to Patients with EGFR-undetectable Metastatic Colon or Rectal Cancer that is Refractory to Chemotherapy
Conditions: Colorectal Neoplasms; Metastases; Neoplasm |
| 4. | | Recruiting | Photodynamic therapy with talaporfin sodium (LS11) in treating patients with refractory colorectal liver metastases
Conditions: Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis |
| 5. | | Recruiting | Rectal Aberrant Crypt Foci and Other Intermediate Biomarkers for Sporadic Colorectal Neoplasia: Cross-Sectional Prevalence and Modulation by Celecoxib
Conditions: Adenoma; Colorectal Neoplasms |
| 6. | | Recruiting | Tezacitabine and oxaliplatin for the treatment of patients with metastatic colorectal cancer
Condition: Colorectal Neoplasms |
| 7. | | Recruiting | Mistletoe Extract and Gemcitabine for the Treatment of Solid Tumor Cancers
Conditions: Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms |
| 8. | | Recruiting | Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver
Condition: Colorectal Neoplasms |
| 9. | | Recruiting | A Phase I/II Trial of Vaccination with Mutant Ras Peptide Pulsed Dendritic Cells in the Treatment of HLA A2.1 Positive Patients with Colorectal Cancer
Conditions: Colorectal Neoplasm; Neoplasm Metastasis |
| 10. | | Recruiting | Phase I Dose-finding Study of E7070 in Combination with Irinotecan
Conditions: Colorectal Cancer; Colorectal Carcinoma; Colorectal Tumors; Pulmonary Neoplasms; Pulmonary Cancer |
| 11. | | Recruiting | Chemotherapy Administered Every 2 Weeks with or without Pegfilgrastim (Neulasta) in Subjects with Advanced Colon Cancer
Conditions: Colon Cancer; Colorectal Cancer; Rectal Cancer |
| 12. | | Recruiting | Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Conditions: stage II anal cancer; stage IIIA anal cancer; stage IIIB anal cancer; squamous cell carcinoma of the anus |
| 13. | | Recruiting | Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Conditions: stage II colon cancer; adenocarcinoma of the colon |
| 14. | | Recruiting | Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colon Cancer
Conditions: recurrent colon cancer; stage II colon cancer; stage III colon cancer; stage IV colon cancer |
| 15. | | Recruiting | Vaccine Therapy and Sargramostim in Treating Patients With Metastatic Colorectal or Noncolorectal Cancer
Conditions: adult solid tumor; Colon Cancer; Rectal Cancer |
| 16. | | Recruiting | ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer
Conditions: Colorectal Cancer; Metastases |
| 17. | | Recruiting | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; liver metastases |
| 18. | | Recruiting | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
Conditions: Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer |
| 19. | | Recruiting | Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants
Conditions: Colon Cancer; Rectal Cancer |
| 20. | | Recruiting | Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 21. | | Recruiting | Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
Conditions: stage I colon cancer; adenocarcinoma of the colon |
| 22. | | Recruiting | ABX-EGF in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Chemotherapy
Conditions: adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ... |
| 23. | | Recruiting | Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
Conditions: adenocarcinoma of the rectum; stage III rectal cancer; stage II rectal cancer |
| 24. | | Recruiting | AG2037 in Treating Patients With Metastatic Cancer of the Colon or Rectum That Has Not Responded to Fluorouracil and Leucovorin
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; adenocarcinoma of the colon; ... |
| 25. | | Recruiting | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
Conditions: adenocarcinoma of the colon; stage III colon cancer |
| 26. | | Not yet recruiting | Computed Tomographic Colonography in Screening Healthy Participants for Colorectal Cancer
Conditions: Colon Cancer; Rectal Cancer |
| 27. | | Recruiting | Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer
Conditions: recurrent rectal cancer; stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum |
| 28. | | Recruiting | Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
Conditions: Colon Cancer; Diarrhea; Rectal Cancer |
| 29. | | Recruiting | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
Conditions: adult solid tumor; Colon Cancer; Rectal Cancer |
| 30. | | Recruiting | Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
Conditions: stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum |
| 31. | | Recruiting | A Trial of ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer Following Treatment with Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
Conditions: Colorectal Cancer; Metastases |
| 32. | | Not yet recruiting | FR901228 in Treating Patients With Advanced Colorectal Cancer That Has Progressed After a Previous Fluorouracil-Containing Regimen
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 33. | | Recruiting | SU011248 in Treating Patients With Metastatic Colorectal Adenocarcinoma (Cancer) That Has Not Responded to Previous Treatment With Irinotecan, Oxaliplatin, and a Fluoropyrimidine With or Without Bevacizumab
Conditions: stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; ... |
| 34. | | Recruiting | Phase II Clinical Trial in Patients with Metastatic Colorectal Cancer
Conditions: Colon Cancer; Rectal Cancer |
| 35. | | Not yet recruiting | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer
Conditions: stage III rectal cancer; adenocarcinoma of the rectum; stage II rectal cancer |
| 36. | | Recruiting | OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer
Conditions: recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer |
| 37. | | Not yet recruiting | Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
Conditions: adenocarcinoma of the rectum; stage II rectal cancer; stage III rectal cancer |
| 38. | | Recruiting | DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma
Conditions: Colon Cancer; Rectal Cancer |
| 39. | | Recruiting | Adjuvant Oxaliplatin and Capecitabine Compared With Fluorouracil and Leucovorin in Treating Chemotherapy-Naïve (Not Previously Treated) Patients Who Have Undergone Resection for Stage III Colon Cancer
Condition: stage III colon cancer |
| 40. | | Recruiting | Trial for First-Line Treatment of Colorectal Cancer
Condition: Colorectal Cancer |
| 41. | | Recruiting | Comparison of Adjuvant Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients With Resected Stage III Colon Cancer
Conditions: stage III colon cancer; adenocarcinoma of the colon |
| 42. | | Recruiting | Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Conditions: Quality of Life; stage IV colon cancer; recurrent colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 43. | | Recruiting | Celecoxib and/or Selenium in Treating Patients With Adenomatous Colorectal Polyps
Conditions: Colon Cancer; Rectal Cancer |
| 44. | | Recruiting | SU011248 in Patients with Metastatic Colorectal Cancer who Previously Failed Treatment with Irinotecan-, Oxaliplatin-, and Fluoropyrimidine, with and without Bevacizumab
Conditions: Colorectal Cancer; Neoplasm Metastasis |
| 45. | | Recruiting | FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer |
| 46. | | Recruiting | Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer |
| 47. | | Recruiting | Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
Conditions: Colon Cancer; Rectal Cancer |
| 48. | | Recruiting | Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
Conditions: adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; recurrent rectal cancer; stage IV colon cancer; ... |
| 49. | | Recruiting | Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Conditions: Anal Cancer; Drug Toxicity; radiation enteritis; Rectal Cancer |
| 50. | | Recruiting | Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ... |
